Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.32, down -0.48% from the previous day, while the S&P 500 lost 0.27%. The stock has gained 44.63% in the past month, outperforming the Medical sector and the S&P 500.

Analysts expect Ginkgo Bioworks Holdings, Inc. to post earnings of -$1.45 per share, a 59.72% increase year-over-year. Revenue is projected to reach $45.08 million, up 29.69% from the same quarter last year. Positive estimate revisions can indicate optimism about the company’s outlook.

The Zacks Rank system, with a #3 Hold rank for Ginkgo Bioworks Holdings, Inc., has a strong track record of outperformance. The company is part of the Medical – Biomedical and Genetics industry, which ranks in the top 29% of all industries. Follow DNA’s performance on Zacks.com for more insights.

Zacks has identified a top semiconductor stock with massive growth potential in Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is forecasted to grow from $452 billion in 2021 to $803 billion by 2028. Don’t miss out on this opportunity.

Read more at Nasdaq: Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know